Brief: Lidds Announces Positive Meeting With The Swedish Medical Products Agency
May 18 (Reuters) - Lidds AB LIDDS.ST :
* REG-LIDDS ANNOUNCES POSITIVE MEETING WITH THE SWEDISH MEDICAL PRODUCTS AGENCY, CONFIRMING
THE
LIPROCA® DEPOT PHASE III STUDY DESIGN
Source text for Eikon: ID:nGNE1qdl2m
Further company coverage: LIDDS.ST
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Lidds AB
See all newsBrief: Liquidator To Apply For Lidds To Be Declared Bankrupt
Brief: Lidds To Delist Shares From Nasdaq First North
Brief: Lidds Proposes Voluntary Liquidation And Delisting
Brief: Lidds Decides To Terminate Process Regarding Reverse Acquisition Of Proport Invest
Brief: Lidds Signs Agreement For Reverse Takeover Of Proport Invest